![]() Northwest Biotherapeutics Northwest Biotherapeutics is a biotechnology company focused on developing and commercializing immunotherapy products to treat cancer. | ||
Founding Date | Founding Date 2000 | Founding Date 1998 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Tübingen, DE HQ Ottignies Louvain La Neuve, BE Wiesbaden, DE Amsterdam, NL Basel, CH Boston, US | Locations Bethesda, US HQ |
Employees | Employees 82517% decrease | Employees 1721% increase |
Valuation ($) | Valuation ($) 648.3 m | Valuation ($) 349.5 m |
Financial | ||
Revenue (est.) | Revenue (est.) €535.2m (FY, 2024) | Revenue (est.) $1.4m (FY, 2025) |
Net income | Net income €162.2m (FY, 2024) | Net income ($60.2m) (FY, 2025) |
Funding | ||
Total funding raised | Total funding raised $ 1.1b | Total funding raised $ 135.9m |

Northwest Biotherapeutics is a biotechnology company focused on developing and commercializing immunotherapy products to treat cancer.
View company